Table 2.
Clinical characteristics | Total/percentage | |
---|---|---|
Age | Range: 0.2–15.5 years | Median: 3.0 |
Gender | Female | 29/57% |
Male | 22/43% | |
Growth | Height/length ≤ 3rd centile | 25/49% |
Weight ≤ 3rd centile | 21/41% | |
Formula | Infant | 15/29% |
Junior | 35/69% | |
Advance | 1/2% | |
Feeding route | Oral/gastric | 27/53% |
Jejunal | 19/37% | |
Gastric and jejunal | 5/10% | |
PPI use | Data available in 44 patients | 40/91% |
Primary treatment | Phosphate supplements | 38/75% |
Formula change | 13/25% |
Abbreviation: PPIs, proton pump inhibitors.